Olaf Koch
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Dermatology top 5%
- Cutaneous lymphoproliferative disorders research
Papers in
- Oncology 11
- Cancer Treatment and Pharmacology 2
- Cancer-related Molecular Pathways 2
- Co-authors
- Matthias Volkenandt (8 shared papers)Wolfgang E. Berdel (3 shared papers)Achim Heinecke (2 shared papers)Joseph R. Bertino (6 shared papers)Jens Atzpodien (4 shared papers)Carsten Müller‐Tidow (5 shared papers)J. van de Loo (2 shared papers)Thomas Büchner (1 shared paper)
- Journals
- Blood (2 papers)Leukemia Research (2 papers)British Journal of Haematology (2 papers)Journal of Clinical Oncology (1 paper)British Journal of Dermatology (1 paper)
- Partner nations
- GermanyUnited StatesItaly
In The Last Decade
Olaf Koch
35 papers receiving 441 citations
Peers
Comparison fields: 5 of 67
- Hematology 144
- Dermatology 78
- Oncology 162
- Pathology and Forensic Medicine 91
- Chemical Health and Safety 3
Countries citing papers authored by Olaf Koch
This map shows the geographic impact of Olaf Koch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olaf Koch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olaf Koch more than expected).
Fields of papers citing papers by Olaf Koch
This network shows the impact of papers produced by Olaf Koch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olaf Koch. The network helps show where Olaf Koch may publish in the future.
Co-authors
The 25 scholars most cited alongside Olaf Koch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 97 | |
| 2 | 2002 | 53 | |
| 3 | 1999 | 40 | |
| 4 | 2000 | 27 | |
| 5 | 1993 | 26 | |
| 6 | 2012 | 25 | |
| 7 | 1992 | 23 | |
| 8 | 2006 | 20 | |
| 9 | 1993 | 19 | |
| 10 | 1993 | 17 | |
| 11 | 2014 | 16 | |
| 12 | 1993 | 11 | |
| 13 | 2002 | 11 | |
| 14 | 2003 | 8 | |
| 15 | 2003 | 6 | |
| 16 | 1979 | 6 | |
| 17 | Combination of chemotherapy and interferon alfa-2b in the treatment of chronic myelogenous leukemia. | 1993 | 6 |
| 18 | 1994 | 5 | |
| 19 | 2003 | 5 | |
| 20 | 1998 | 5 |
About Olaf Koch
Olaf Koch is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Dermatology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 464 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Cutaneous lymphoproliferative disorders research (4 papers), Immune Cell Function and Interaction (3 papers), Chronic Myeloid Leukemia Treatments (2 papers), Multiple Myeloma Research and Treatments (2 papers), T-cell and B-cell Immunology (2 papers), Cancer Treatment and Pharmacology (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Hematology (144 citations), Dermatology (78 citations), Oncology (162 citations), Pathology and Forensic Medicine (91 citations) and Chemical Health and Safety (3 citations). Olaf Koch has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Matthias Volkenandt, Wolfgang E. Berdel, Achim Heinecke, Joseph R. Bertino, Jens Atzpodien, Carsten Müller‐Tidow, J. van de Loo, Thomas Büchner, Cristina Sauerland and Andrea Schumacher. Their work appears in journals such as Blood, Leukemia Research, British Journal of Haematology, Journal of Clinical Oncology and British Journal of Dermatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.